Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Korro Bio (KRRO) Research & Development (2019 - 2025)

Historic Research & Development for Korro Bio (KRRO) over the last 7 years, with Q3 2025 value amounting to $13.8 million.

  • Korro Bio's Research & Development fell 1343.02% to $13.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $71.6 million, marking a year-over-year increase of 1522.8%. This contributed to the annual value of $63.6 million for FY2024, which is 1115.46% up from last year.
  • According to the latest figures from Q3 2025, Korro Bio's Research & Development is $13.8 million, which was down 1343.02% from $21.0 million recorded in Q2 2025.
  • In the past 5 years, Korro Bio's Research & Development ranged from a high of $21.0 million in Q2 2025 and a low of $3.4 million during Q4 2022
  • Its 5-year average for Research & Development is $14.7 million, with a median of $14.7 million in 2023.
  • Per our database at Business Quant, Korro Bio's Research & Development tumbled by 7309.08% in 2022 and then skyrocketed by 34935.9% in 2023.
  • Over the past 5 years, Korro Bio's Research & Development (Quarter) stood at $12.8 million in 2021, then plummeted by 73.09% to $3.4 million in 2022, then skyrocketed by 349.36% to $15.4 million in 2023, then increased by 9.99% to $17.0 million in 2024, then decreased by 18.52% to $13.8 million in 2025.
  • Its last three reported values are $13.8 million in Q3 2025, $21.0 million for Q2 2025, and $19.7 million during Q1 2025.